New Study Says Incretin Therapy Drugs May Cause Pancreatic Cell Growth

WILMINGTON, Del. — Type 2 diabetes patients treated with incretin therapy drugs such as Januvia and Byetta may be exposed to pancreatic cell growth and damage that could turn cancerous, according to the results of a newly published study.

The abstract, published March 22 in the American Diabetes Association’s “Diabetes” journal, says incretin therapy caused “a marked expansion of the exocrine and endocrine pancreatic compartments.”

Drs. Alexandra E. Butler, Martha Campbell-Thompson, Tatyana Gurlo, David W. Dawson, Mark Atkinson and Peter C. Butler authored the study, entitled “Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased …